Adjusting the dose or taking the supplement with food frequently reduces early discomfort
(2025) GLP-1RA Use and Thyroid Cancer Risk
Halim MA, Degerblad M, Sundbom M, Karlbom U, Holst JJ, Webb DL, et al
Lori Suet Hang 1 , Richard Sawatzky 2 , Joanne Greenhalgh 3 , Kara Schick-Makaroff 4 1 Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada, 2 School of Nursing, Trinity Western University, Vancouver, British Columbia, Canada, 3 School of Sociology and Social Policy, University of Leeds, Leeds, UK, 4 Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :VP17 Aims People receiving dialysis commonly experience anxiety symptoms and low quality of life, yet the problem remains under-addressed
Both are dual agonists designed to produce superior weight loss compared to single-receptor medications like semaglutide , but their different receptor combinations create distinct metabolic effects, side effect profiles, and practical considerations that matter when choosing between them